Galapagos NV
GLPG
#4569
Rank
HK$16.66 B
Marketcap
HK$252.88
Share price
0.45%
Change (1 day)
20.10%
Change (1 year)

Market capitalization of Galapagos NV (GLPG)

Market cap: HK$16.66 Billion

As of December 2025 Galapagos NV has a market cap of HK$16.66 Billion. This makes Galapagos NV the world's 4569th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Galapagos NV from 2008 to 2025

End of year Market Cap

Year Marketcap Change
2025HK$16.66 B19.31%
2024HK$13.96 B-33.24%
2023HK$20.92 B-8.36%
2022HK$22.82 B-19.86%
2021HK$28.48 B-43.25%
2020HK$50.19 B-52.29%
2019HK$105.21 B167.69%
2018HK$39.30 B4.75%
2017HK$37.52 B62.38%
2016HK$23.10 B20.95%
2015HK$19.10 B331.6%
2014HK$4.42 B-8.92%
2013HK$4.86 B10.95%
2012HK$4.38 B58.12%
2011HK$2.77 B-16.32%
2010HK$3.31 B67.51%
2009HK$1.97 B148.88%
2008HK$0.79 B

End of Day market cap according to different sources

On Dec 21st, 2025 the market cap of Galapagos NV was reported to be:

HK$16.58 Billion
by Nasdaq info icon info icon
HK$16.58 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
AstraZeneca
AZN
HK$2.207 T 13,149.16%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
HK$3.888 T 23,235.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$912.73 B 5,377.30%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
HK$3.127 T 18,667.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
HK$0.86 B-94.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$1.694 T 10,068.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$278.29 B 1,570.05%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
HK$765.23 B 4,492.13%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
HK$2.036 T 12,123.72%๐Ÿ‡บ๐Ÿ‡ธ USA